Earl M. Collier Jr.

Filings by Earl M. Collier Jr. span 4 companies, the busiest being Genzyme Corp, Capricor Therapeutics, Inc. and TESARO, Inc. We count 20 filings; the first trade dates from 21 July 2006 and the latest from 27 February 2025.

Both buying and selling appear: 1 purchase worth €27k, against 5 sales worth €8.0M. On balance, insiders were net sellers of €8.0M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 3 share grants and 8 option exercises.

The newest entry dates from 28 February 2025: an option exercise of €994, in Capricor Therapeutics, Inc. The last purchase on record was published on 12 October 2023, which is 1,108 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.